MX9703191A - Anticuerpos contra proteinas alogenicas y xenogenicas, su uso en diagnostico y terapia y metodos para la determinacion de los mismos. - Google Patents
Anticuerpos contra proteinas alogenicas y xenogenicas, su uso en diagnostico y terapia y metodos para la determinacion de los mismos.Info
- Publication number
- MX9703191A MX9703191A MX9703191A MX9703191A MX9703191A MX 9703191 A MX9703191 A MX 9703191A MX 9703191 A MX9703191 A MX 9703191A MX 9703191 A MX9703191 A MX 9703191A MX 9703191 A MX9703191 A MX 9703191A
- Authority
- MX
- Mexico
- Prior art keywords
- diagnosis
- therapy
- methods
- determination
- antibodies against
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/734—Complement-dependent cytotoxicity [CDC]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invencion se relaciona con métodos de diagnostico para la deteccion de anticuerpos naturales que reconocen proteínas que se pueden extraer de organos de mamífero que tienen un peso molecular de aproximadamente 14 unidades Kda dotados con actividad antitumoral cuando se administran a especies xenogénicas.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MIMI94A002238 | 1994-11-04 | ||
| IT94MI002238A IT1276860B1 (it) | 1994-11-04 | 1994-11-04 | Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione |
| PCT/EP1995/004239 WO1996014340A1 (en) | 1994-11-04 | 1995-10-30 | Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9703191A true MX9703191A (es) | 1997-07-31 |
| MXPA97003191A MXPA97003191A (es) | 1997-12-01 |
Family
ID=
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1020756A1 (en) | Use of angiogenic factor vegf145 in treating cardiovascular disease | |
| ATE451929T1 (de) | Von casein abgeleitete peptide und deren anwendung für die therapie | |
| DE69937294D1 (de) | Von cyclophilin b abstammende tumorantigen-peptide | |
| PT749317E (pt) | Aplicacoes terapeuticas de produtos dimericos de proteinas bactericidas indutoras da permeabilidade | |
| ATE257390T1 (de) | Verwendung eines bpi proteinproduktes als antithrombotisches mittel | |
| WO1998008542A3 (en) | Compounds and methods for treatment and diagnosis of mycobacterial infections | |
| DE69632625D1 (de) | Mykrobakterielle proteine, mikroorganismen welche diese produzieren und ihre verwendung als impfstoff und zum nachweis von zuberkulose | |
| DE69719754D1 (de) | Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung | |
| DE60028965D1 (de) | Materialen zur vermehrung von weichgewebe und deren herstellungs- und verwendungsmethoden | |
| MX9604402A (es) | Proteina similar a albumina serica humana. | |
| NZ505834A (en) | Compositions containing polypeptides isolated from mycobacterium vaccae and methods for their use | |
| FI953093A0 (fi) | Menetelmiä, joilla voidaan havaita ja hoitaa yksilöitä, joilla on epänormaaleja soluja, jotka ekspressoivat HLA-A2/tyrosinaasi-peptidiantigeenejä | |
| NO963487L (no) | Isolerte, tyrosinaseavledete peptider, samt anvendelser derav | |
| Baltz et al. | Isolation and characterization of amyloid enhancing factor (AEF) | |
| CA2194485A1 (en) | Endothelial lining effects and treatment of vasospastic disorders | |
| KR890700353A (ko) | 면역독소의 면역억제 기저 사람치료법 | |
| MX9703191A (es) | Anticuerpos contra proteinas alogenicas y xenogenicas, su uso en diagnostico y terapia y metodos para la determinacion de los mismos. | |
| CA2139518A1 (en) | Antigenic regions of tlp complexes and antibodies against the same | |
| PT782630E (pt) | Gene da doenca poliquistica do rim | |
| EP1849800A3 (en) | Moraxella catarrhalis proteins | |
| WO1991017187A3 (en) | A 35kd tumor associated protein antigen: uses and methods of detection | |
| AU1318797A (en) | Peptides and uses thereof for therapy of celiac diseases | |
| GB2259706B (en) | Porcine adipocyte antigens and their use in the immunological control of fat | |
| EP0500921A4 (en) | Na-k-atpase inhibiting natriuretic substances | |
| Gesu et al. | Epidemiological aspects of bacteremia in Italy: Observations in the microbiology laboratory of the University of Genoa, Italy. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |